vs

Side-by-side financial comparison of Finward Bancorp (FNWD) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $16.5M, roughly 2.0× Finward Bancorp). Finward Bancorp runs the higher net margin — 12.0% vs -28.1%, a 40.1% gap on every dollar of revenue. On growth, Finward Bancorp posted the faster year-over-year revenue change (1.1% vs -18.9%). Finward Bancorp produced more free cash flow last quarter ($9.0M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -19.1%).

Finward Bancorp is a U.S.-headquartered regional bank holding company. It offers a full range of retail and commercial banking products and services, including deposit accounts, personal and mortgage loans, small business financing, and wealth management solutions, primarily serving individual customers and small to mid-sized enterprises in its local operating regions.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

FNWD vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
2.0× larger
RXST
$32.6M
$16.5M
FNWD
Growing faster (revenue YoY)
FNWD
FNWD
+20.0% gap
FNWD
1.1%
-18.9%
RXST
Higher net margin
FNWD
FNWD
40.1% more per $
FNWD
12.0%
-28.1%
RXST
More free cash flow
FNWD
FNWD
$11.3M more FCF
FNWD
$9.0M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-19.1%
FNWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FNWD
FNWD
RXST
RXST
Revenue
$16.5M
$32.6M
Net Profit
$2.0M
$-9.2M
Gross Margin
77.5%
Operating Margin
11.0%
-34.8%
Net Margin
12.0%
-28.1%
Revenue YoY
1.1%
-18.9%
Net Profit YoY
-5.6%
-54.1%
EPS (diluted)
$0.46
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNWD
FNWD
RXST
RXST
Q4 25
$16.5M
$32.6M
Q3 25
$17.4M
$30.3M
Q2 25
$16.6M
$33.6M
Q1 25
$15.5M
$37.9M
Q4 24
$16.3M
$40.2M
Q3 24
$14.9M
$35.3M
Q2 24
$14.6M
$34.9M
Q1 24
$25.3M
$29.5M
Net Profit
FNWD
FNWD
RXST
RXST
Q4 25
$2.0M
$-9.2M
Q3 25
$3.5M
$-9.8M
Q2 25
$2.2M
$-11.8M
Q1 25
$455.0K
$-8.2M
Q4 24
$2.1M
$-5.9M
Q3 24
$606.0K
$-6.3M
Q2 24
$143.0K
$-6.1M
Q1 24
$9.3M
$-9.1M
Gross Margin
FNWD
FNWD
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
FNWD
FNWD
RXST
RXST
Q4 25
11.0%
-34.8%
Q3 25
20.5%
-40.1%
Q2 25
12.7%
-41.6%
Q1 25
4.0%
-28.2%
Q4 24
16.3%
-21.5%
Q3 24
2.7%
-26.1%
Q2 24
0.9%
-23.9%
Q1 24
40.6%
-36.2%
Net Margin
FNWD
FNWD
RXST
RXST
Q4 25
12.0%
-28.1%
Q3 25
20.1%
-32.4%
Q2 25
12.9%
-35.0%
Q1 25
2.9%
-21.6%
Q4 24
12.9%
-14.8%
Q3 24
4.1%
-17.9%
Q2 24
1.0%
-17.4%
Q1 24
36.7%
-30.8%
EPS (diluted)
FNWD
FNWD
RXST
RXST
Q4 25
$0.46
$-0.22
Q3 25
$0.81
$-0.24
Q2 25
$0.50
$-0.29
Q1 25
$0.11
$-0.20
Q4 24
$0.50
$-0.14
Q3 24
$0.14
$-0.16
Q2 24
$0.03
$-0.16
Q1 24
$2.17
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNWD
FNWD
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$174.7M
$275.7M
Total Assets
$2.0B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNWD
FNWD
RXST
RXST
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
FNWD
FNWD
RXST
RXST
Q4 25
$174.7M
$275.7M
Q3 25
$165.5M
$276.0M
Q2 25
$154.3M
$278.0M
Q1 25
$151.8M
$279.3M
Q4 24
$151.4M
$281.2M
Q3 24
$159.6M
$277.3M
Q2 24
$148.6M
$275.2M
Q1 24
$151.6M
$163.9M
Total Assets
FNWD
FNWD
RXST
RXST
Q4 25
$2.0B
$311.8M
Q3 25
$2.1B
$308.5M
Q2 25
$2.1B
$309.0M
Q1 25
$2.0B
$313.0M
Q4 24
$2.1B
$318.6M
Q3 24
$2.1B
$310.5M
Q2 24
$2.1B
$305.5M
Q1 24
$2.1B
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNWD
FNWD
RXST
RXST
Operating Cash FlowLast quarter
$9.9M
$-1.1M
Free Cash FlowOCF − Capex
$9.0M
$-2.3M
FCF MarginFCF / Revenue
54.8%
-6.9%
Capex IntensityCapex / Revenue
5.2%
3.5%
Cash ConversionOCF / Net Profit
4.99×
TTM Free Cash FlowTrailing 4 quarters
$10.6M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNWD
FNWD
RXST
RXST
Q4 25
$9.9M
$-1.1M
Q3 25
$1.2M
$-1.2M
Q2 25
$4.8M
$-4.4M
Q1 25
$-3.8M
$-8.8M
Q4 24
$9.8M
$-4.3M
Q3 24
$-3.7M
$650.0K
Q2 24
$2.8M
$-4.0M
Q1 24
$-25.0K
$-9.3M
Free Cash Flow
FNWD
FNWD
RXST
RXST
Q4 25
$9.0M
$-2.3M
Q3 25
$1.0M
$-1.8M
Q2 25
$4.5M
$-5.9M
Q1 25
$-4.0M
$-9.4M
Q4 24
$6.7M
$-5.1M
Q3 24
$-4.2M
$-453.0K
Q2 24
$1.1M
$-5.5M
Q1 24
$-736.0K
$-11.3M
FCF Margin
FNWD
FNWD
RXST
RXST
Q4 25
54.8%
-6.9%
Q3 25
6.0%
-5.8%
Q2 25
27.0%
-17.6%
Q1 25
-25.7%
-24.8%
Q4 24
41.2%
-12.7%
Q3 24
-28.5%
-1.3%
Q2 24
7.6%
-15.9%
Q1 24
-2.9%
-38.2%
Capex Intensity
FNWD
FNWD
RXST
RXST
Q4 25
5.2%
3.5%
Q3 25
0.9%
1.9%
Q2 25
1.7%
4.6%
Q1 25
1.2%
1.5%
Q4 24
18.8%
2.1%
Q3 24
3.4%
3.1%
Q2 24
11.2%
4.4%
Q1 24
2.8%
6.7%
Cash Conversion
FNWD
FNWD
RXST
RXST
Q4 25
4.99×
Q3 25
0.34×
Q2 25
2.22×
Q1 25
-8.37×
Q4 24
4.66×
Q3 24
-6.15×
Q2 24
19.23×
Q1 24
-0.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FNWD
FNWD

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons